Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bagayoko

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
Viruses|October 26, 2024
SARS-CoV-2 Antibody Seroprevalence in Gabon: Findings from a Nationwide Household Serosurvey in a Sub-Saharan Africa CountrySamira Zoa-Assoumou, Paulin Essone-Ndong, Rafiou Adamou, et al.
Neuroepidemiology|January 19, 2022
Prevalence and Risk Factors Associated with Epilepsy in Six Health Districts of Mali: A Community-Based Cross-Sectional and Nested Case-Control StudyHousseini Dolo, Fatoumata Dite Nènè Konipo, Fanta Sow, et al.
Plos Pathogens|August 24, 2023
Druggable redox pathways against Mycobacterium abscessus in cystic fibrosis patient-derived airway organoidsStephen Adonai Leon-Icaza, Salimata Bagayoko, Romain Vergé, et al.
The Lancet. Infectious Diseases|October 17, 2017
Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety reportPierre-Stéphane Gsell, Anton Camacho, Adam J Kucharski, et al.
Molecular Cell|May 20, 2022
Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung epithelial cellsRémi Planès, Miriam Pinilla, Karin Santoni, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 13, 2025
Vaccination strategies for Ebola in the democratic republic of Congo: the WHO-Ebola modeling collaborationMarco Ajelli, Jean-Jacques Muyembe, Alhassane Touré, et al.
BMC Medicine|November 7, 2024
rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l'essai proches)Conall H Watson, Pierre-Stéphane Gsell, Yper Hall, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Viruses|October 26, 2024
SARS-CoV-2 Antibody Seroprevalence in Gabon: Findings from a Nationwide Household Serosurvey in a Sub-Saharan Africa CountrySamira Zoa-Assoumou, Paulin Essone-Ndong, Rafiou Adamou, et al.
Neuroepidemiology|January 19, 2022
Prevalence and Risk Factors Associated with Epilepsy in Six Health Districts of Mali: A Community-Based Cross-Sectional and Nested Case-Control StudyHousseini Dolo, Fatoumata Dite Nènè Konipo, Fanta Sow, et al.
Plos Pathogens|August 24, 2023
Druggable redox pathways against Mycobacterium abscessus in cystic fibrosis patient-derived airway organoidsStephen Adonai Leon-Icaza, Salimata Bagayoko, Romain Vergé, et al.
The Lancet. Infectious Diseases|October 17, 2017
Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety reportPierre-Stéphane Gsell, Anton Camacho, Adam J Kucharski, et al.
Molecular Cell|May 20, 2022
Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung epithelial cellsRémi Planès, Miriam Pinilla, Karin Santoni, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 13, 2025
Vaccination strategies for Ebola in the democratic republic of Congo: the WHO-Ebola modeling collaborationMarco Ajelli, Jean-Jacques Muyembe, Alhassane Touré, et al.
BMC Medicine|November 7, 2024
rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l'essai proches)Conall H Watson, Pierre-Stéphane Gsell, Yper Hall, et al.
Pageof 13